He is focused on the identification of early biomarkers of Alzheimer's disease in asymptomatic stages using 5xFAD transgenic mice.

Through the study of hyperexcitability changes and spatio-temporal dynamics of the neurodegenerated cerebral cortex he is working on the indentification of novel early biomarkers that could be clinically exploit to detect early neurodegeneration-linked to hyperexcitability in asymptomatic patients.